← Back to catalogue

Tendril STS 2088TC Lead

FDA PMA

Class III (US FDA PMA)

PMA P910023

by Abbott Medical

Identity

Trade Name
CADENCE(R) TIERED THERAPY DEFIBRILLATION SYSTEM FDA PMA
Generic Name
Implantable cardioverter defibrillator (non-CRT) FDA PMA

Identifiers

PMA Number
P910023 FDA PMA
FDA Product Code
LWS FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
Cardiovascular FDA PMA
FDA Decision
APPR Approved FDA PMA

The Tendril STS 2088TC Lead is an implantable cardioverter defibrillator lead designed for use with the Cadence Tiered Therapy Defibrillator System. It is intended for patients with a history of hemodynamically compromising ventricular tachyarrhythmias, including those who have experienced cardiac arrest not associated with acute myocardial infarction or have ventricular tachyarrhythmias.

This lead is supplied as part of a system that includes defibrillation capabilities and may be used with Ventritex epicardial defibrillation leads, CPI defibrillation patch leads, and superior vena cava spring leads. The device is FDA PMA approved and is intended for use as a replacement for CPI automatic implantable cardioverter defibrillators when used with CPI patch leads or SVC leads.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Abbott Medical

Sources (1)

  • FDA PMA P910023 24 fields · synced Sep 18, 2026